Summary The DNA-binding fluorescent dye Hoechst 33342 (H33342) has been used in a series of investigations of the vascular parameters of two murine tumours. This dye has been shown, to have a short half-life in the circulation (T-less than 2min), but is stably bound for at least 2h after it enters cells. It can be used in morphometric studies on frozen sections to determine the effective vascular volume, the capillary fraction and the size distribution of blood vessels in each tumour. These latter two parameters cannot be deduced from the less labour intensive techniques using radioactive isotopes.
The growth of solid tumours depends on the tumour vasculature and pattern of blood flow, as does the response to most forms of cancer therapy. However, neovascularization is often inadequate, resulting in areas deprived of nutrients and oxygen (Thomlinson & Gray, 1955; Tannock 1968) . The regions of local tissue hypoxia are thought to be one of the major determinants of tumour response to radiation (Gray et al., 1953; Thomlinson & Craddock, 1967) , and limitations in blood circulation and drug delivery have been implicated in the resistance of tumours to chemotherapy (Siemann, 1982) . It is therefore important to understand the processes and patterns of vascular development in different tumour types. Over the years, vascular development in tumours has been extensively studied using a variety of techniques (for review see Peterson, 1978) . These investigative methods can be broadly classified into two types: (a) those which identify the total vascular bed, such as histological stains applied to post-mortem samples and (b) those techniques which identify only the perfused fraction of the vasculature, such as radioisotopes.
Since the functioning microvasculature of an organ or tumour at any moment may represent only part of the total vascular bed, in vivo estimates of functional vascularity may give a lower value than measures of the total vascular bed (Tannock & Steel, 1969; Murray et al., 1987) . This may be a more meaningful index of the nutritional status of the tissue than methods which identify the total vessel network, although it is also important to know whether the nonperfused vessels are temporarily or permanently closed. Studies of functional circulation in tumours have been mainly limited to radioisotope techniques using y-emitting tracers; with these methods no direct histological assessment of tissues and their vessel networks are made. This paper describes a new in vivo technique, using a fluorescent DNA stain-H33342, for the identification and quantitation of functional vasculature from histological samples.
H33342 is a bisbenzimidazole dye which fluoresces strongly under ultraviolet light. It Jovin & Jovin, 1977) . Because of its low toxicity to viable cells, H33342 is extensively used in flow cytometry studies for cells labelled in vitro (Preisler, 1978; Durand & Olive, 1982) . Its use as an in vivo marker has been suggested by Reinhold and Visser (1983) and has been adopted by Chaplin et al., 1985 . Using tumours growing in 'sandwich' observation chambers Reinhold and Visser observed by in vivo trans-illumination that, following an intravenous injection of H33342, cells lining the blood vessels were the first to incorporate the drug. Chaplin et al. (1985) have subsequently used H33342 injections in vivo, in combination with flow cytometry, and have documented large differences in the fluorescence intensity between different cells in the tumour population. They use these differences in drug concentration to deduce the position of each cell relative to a perfused vessel at the time of injection. Therefore, although H33342 is not a specific stain of endothelial cells, its rapid uptake into cells, and limited diffusibility across cell layers may make it a useful compound for indentifying functional vascular networks.
We have extended the technique described by Reinhold and Visser (1983) to allow H33342-stained vessels to be identified in histological samples. The vascular fraction and profiles of vessel size have been quantitated in two different experimental tumours over a range of tumour sizes. We have compared the results with those obtained in the same tumour types using the more conventional techniques of injecting 5"Cr-labelled red blood cells and 86RbCl to measure vascular space and relative blood flow. In addition, by combining H33342 injections with the isotope techniques, we have investigated whether H33342 causes any perturbations in the vascular parameters assessed using these tracers. The pharmacokinetics of the drug in vivo, and the stability of H33342 binding in cells are also discussed.
Materials and methods
Two different tumour types were used in this study, CaNT, which is a moderately differentiated adenocarcinoma, and SaF, which is a more rapidly growing anaplastic sarcoma. Both tumours arose spontaneously and have been maintained by serial passage for more than 10 years. They have previously been extensively used in both radiation and hyperthermia studies (Hill & Denekamp, 1979; Hill et al., 1983) . For the present experiments, tumour cell suspensions were prepared by crudely mincing donor tumours and 12-16 week old CBA/Gy f BSVS mice were injected with 0.05ml tumour brei s.c. on the rear dorsum. Prior to treatment, tumours were measured 2-3 times weekly with calipers, and were selected for treatment over a chosen range of volumes between 2 and 1,000 mm3 (i.e. 1.5-12.5mm diameter).
Hoechst 33342 estimates of vascular volume H33342 was obtained from Aldrich Chemicals Ltd (Gillingham, England). Solutions were made up in sterile saline immediately before use. Mice were injected i.v. via one of the lateral tail veins with 0.01 ml g of a 2 or 4mg ml 1 solution (equivalent to doses of 20 or 40mgkg-1). These doses are well below the toxic limits for this drug (LD50 in mice 300mgkg-1, and were chosen as they allowed easy identification of labelled cells in histological sections. Mice were killed 1 min after injection, and the tumours were dissected out and frozen in liquid nitrogen. They were then stored at -70°C until they were sectioned. For each tumour sample, 6pm cryostat sections were cut at three different levels between one pole and the equatorial plane. The sections were air dried and then studied under ultraviolet illumination using a Leitz microscope equipped with an epifluorescent source (magnification x 400).
Blood vessel outlines were identified by the surrounding halo of fluorescent H33342-labelled cells (Figure 1 ). The vascular volume fraction enclosed by these haloes was measured using a point scoring system based on that described by Chalkley (1943) . Briefly, a graticule with a random array of 25 points was focused on an area of the section, and points falling inside rings of fluorescent cells were scored as positive (see Figure 1 ). This procedure was repeated over different areas of the tissue until a minimum of 3,000 points in total had been accumulated from sections cut at the three different levels. This sample size was chosen to give a relative standard errort of approximately 10% on the measured volume fractions (see footnote). The vascular volume fraction* for each sample was calculated as the ratio of positive to total points.
Two intravenously injected isotopes were also used to measure vascular parameters. The vascular space perfused in 30min was measured by 51Cr labelled erythrocytes and the functional perfusion in one minute measured from the 86Rb extraction. Each isotope can be used alone, or if the two isotopes are injected at different times they can be combined to give two independent measurements in each mouse.
51Cr-Red blood cell estimates of vascular volume 51Cr-labelled red blood cells were prepared using a method similar to that described by Song and Levitt (1970) . Five millilitre freshly collected CBA blood was spun at 1,500rpm for 10min, the plasma removed and the red cells incubated for 30 min with 100 pCi Na2 51CrO4ml-1 whole blood. The cells were then spun down, the supernatant removed and sterile PBS added to bring the volume back to 5 ml. The blood was then spun again and the procedure repeated twice more to remove any unbound isotope. After the final washing, the red cells were resuspended in sterile 2% dextrose citrate and PBS (ratio 1:7). Mice were injected i.v. with 0.1 ml of the 5'Cr-labelled blood and killed 30min
later. A blood sample was then obtained from the thorax and the tumour was removed. All samples were weighed and counted in a Wallac 1282 compu-gamma counter for 1,000 sec or as long as was needed to accumulate 5,000 counts.
The vascular volume of the tumours was calculated as:
vascular volue (%) Ix5'Cr activity/g tumour vasclarvolme () =100X 5Cr activity/g blood 86RbCl extraction estimates of vascular perfusion Vascular perfusion relative to the cardiac output was measured using the 86Rb extraction technique (Sapirstein, 1958) . Mice were injected i.v. with 5 pCi 86RbCl and killed 1 min later. The tumours and tail were then removed and the weighted samples counted as described above. The 86Rb counts per gram of tumour were expressed as a percentage of the injected activity (minus residual activity in the tail resulting from leakage at the injection site).
Influence of Hoechst 33342 on the functional vascular volume or vascular perfusion To determine whether injection of H33342 causes any measurable changes in the patterns of blood flow in tumours, an experiment was designed in which H33342 was added to the second injection (i.e. was combined with the 86Rb Cl) to give a dose of 20 or 40mgkg-1. Thirty minutes prior to sacrifice the 5'Cr RBCs were injected i.v., and 29min later 5yCi 86RbCl in PBS, or in a 2 or 4mgml-1 solution of H33342, was also given i.v. The mice were sacrificed 1 min later and blood and tumour samples were counted simultaneously for 86Rb and 5'Cr content. The overlap of energies in the spectrum was determined in reference samples and a simple correction applied to the formol saline, processed, sectioned at three different levels and stained with H & E. The pattern of cell death was usually one of large necrotic regions rather than of individual pyknosed cells. The samples were scored using the system of point scoring described previously. Hoechst 33342 pharmacokinetics (A) The removal of H33342 from the blood following intravenous injection was determined using a method similar to that described by . Blood was collected from the hearts of mice at various times between 0 and 45min after injection, precipitated in ethanol (1/20 dilution) and centrifuged at 4,000rpm for 10min. Samples of supernatant were analysed for fluorescence on a PerkinElmer luminescence spectrometer with excitation at 343nm and emission readings taken at 478nm. The absolute levels of H33342 were then determined by reference to a calibration curve.
(B) Estimates of the 'visible' duration of drug exposure following injection of H33342 were obtained by the histological assessment of tumour samples. Mice were injected intravenously with 20 or 40mgkg-1 H33342 while the blood supply to 100 mm3 CaNT tumours implanted on the back was occluded with a D-shaped clamp. The clamp was then removed at varying intervals (between 1 and 60min after injection) to allow blood and any remaining drug to reperfuse the tumour vascular bed. One minute after removing the clamp, the animal was killed and the tumour removed for sectioning as described above. A scoring system was used to estimate the fluorescence intensity in arbitrary units (range 0-5).
Stability of Hoechst 33342 binding to cells in vivo
The proportion of tumour and stromal cells incorporating H33342 and the stability of the bound compound in vivo were measured in SaF tumours using an Ortho Cytofluorograph. Tumours were removed 1 to 180min after a single dose of 20mgkg-1 H33342 and dissociated into single cells by mincing with scissors and pipetting in PBS. The resulting cell suspension was filtered through 35pm nylon mesh to remove any remaining clumps of cells and then centrifuged at 300g for 10min. The pellet was resuspended in cold PBS and analysed immediately in an Ortho cytofluorograph system 50-H with dedicated 2150 computer. H33342 was excited with a band of ultraviolet light between 357 and 364 nm from a 5 Watt argon ion laser operating at 100 mW. Fluorescent emission was collected above 410 nm. The staining profiles of H33342-labelled tumour cells were analysed after gating on the forward scatter signal to exclude debris and normal tissue cells in the suspension. The proportions of tumour cells with significant drug uptake were determined by comparing the staining profiles of H33342-labelled cells with those of untreated controls.
Results
The concentrations of H33342 remaining in the blood at various times after i.v. injection are shown in Figure 2A . The drug was removed very rapidly from the circulation with an initial exponential decrease for both the doses tested, and a half time of 2 min. This agrees closely with the values obtained by . A slower second component is detectable for the last 0.5% of the drug, with a TI of 1 h, after the higher dose. Figure 2B shows the results of the experiment in which 500mm3 CaNT tumours were clamped just before injection, and the clamp was left on for varying periods before the blood was allowed to reperfuse the tumour. The fluorescence levels in H33342-labelled cells were scored using an arbitrary scale. As with the spectroscopy measurements, the intensity of the visible fluorescence decreased rapidly during the first few minutes after injection, and by 30min very little fluorescence was detectable.
The stability of H33342 binding to cells in vivo was Both populations increased over the first 15min after injection. This corresponds to the time following injection during which H33342 could be measured in the blood and was shown in Figure 2 to be available for incorporation into cells. From 15 to 180min after injection, the populations of fluorescent cells in both categories remained constant. Although redistribution of H33342 between cells could occur during this time without a change in the total proportion of labelled cells, it is probable that the fraction of highly fluorescent cells would be affected. No changes were seen in the number of cells in either population, which suggests that once the drug is bound to DNA it is stable. Figure 1 The data obtained from morphometric analysis of such sections are summarised in Figure 4 . The upper panel shows CaNT tumours at sizes varying from 2 to 1,000 mm3, and the lower panel shows similar data for SaF. The squares are for mice injected with 40mm kg-1 and the circles for 20mgkg-1. There is no significant difference in the values obtained with the 2 doses.
In the carcinoma there seems to be a gradual trend towards lower values at higher sizes, falling from a vascular volume of 4% at 2mm3, to --2.5% at 1,OOOmm3. In the sarcoma the data are more scattered and are consistent with a plateau at 2.8% for sizes up to 100 mm3, followed by a progressive fall to -1% at 1,000mm3.
It was clear from scanning of the sections that larger tumours also showed more overt necrosis. This was quantified for each tumour type from fixed sections stained with H&E and is shown in Figure 5 . The upper panel shows that in CaNT tumours there was virtually no necrosis up to 20mm3, but it rose dramatically to 35% between 100 and 800 mm3. The sarcoma (lower panel) showed 10% necrosis, even at very small sizes, and this rose to 50% in the larger tumours.
The necrotic proportion might reasonably be expected to coincide with areas that are poorly perfused, and therefore in order to relate the vascular tree to the viable tissue it is supporting we have corrected each data point in Figure 4 by the average necrotic fraction for that size of tumour to obtain the percent of the viable tumour mass that is occupied by perfused functional vessels. This is shown in Figure 6 . The low estimates of vascular volume at large sizes are most influenced and the data more nearly fit a straight line at about 3 + 0.5% for both tumours. The scatter of the data for SaF remains greater than that for CaNT. symbols), there is no significant difference between the estimates obtained with the morphometric or the isotope technique. The estimates for SaF tumours are less closely matched, although neither technique gave consistently high or low values. Figure 8 shows the double labelling experiment in which the two isotope measurements used alone were compared with values obtained when H33342 was combined with the second injection. Again both tumours were studied at 100 mm3 and at 500mm3. There were differences in the amount of 51Cr detected in tumours which received H33342 29min later, although in general the differences are small.
The upper panel shows the 51Cr estimates of vascular volume are similar in the groups given isotopes alone or when the fluorescent dye was coinjected min before sacrifice. The estimates are slightly lower for 5 of the 8 groups that received the dye than in corresponding control groups, but 2 of the groups showed increased vascular volumes. There is no significant trend. The lower panel shows a bigger discrepancy and a much larger scatter on the 86Rb data. Mice given H33342 concurrently with the 86RbCl seem to show a reduced perfusion of the tumour compared with those receiving 86RbCl alone. This effect is most marked in the well perfused small SaF tumours (open squares) but the trend is apparent in many of the groups. It appears to be more marked in the mice receiving 40mgkg-1 than in those receiving 20mgkg-1 H33342, and this implies a dose dependent change in the vasculature. Figure 9 shows the histograms of vessel diameter in these two tumours at 10, 100 and 500mm3. A range of vessel diameters from <12.5 pm to> 50pm were measured. The large vessels will be less effective as a nutritive supply because of their reduced surface area:volume ratio and this may be a contributory cause of the higher proportion of necrosis seen in larger tumours. If the vessels below 12.5pm diameter are regarded as the main nutritive capillaries it is possible to calculate the fraction of the total vessels stained with H33342 that forms the nutritive capillary bed. This is illustrated in Figure 10 . The panels show that 70% of the vessels fall in this category for very small CA NT tumours, falling to 20% at 800mm3. By contrast there is little size dependency in SAF, with -35% of the vessels being small in calibre at all sizes.
Discussion
The rapid uptake and stable incorporation of the fluorescent dye H33342 have made it a useful marker in cell sorting studies (Arndt-Jovin & Jovin, 1977) and in vascular studies of thin sandwich tumours that can be transilluminated in vivo (Reinhold & Visser, 1983) . Furthermore, the rapid clearance of the drug from the circulation following injection has been used by Chaplin et Solesvik et al. (1982;  1985) for experimental mouse tumours and for xenografts of human tumours growing in mice. In their studies, the vascular system was filled with a radioopaque contrast medium injected via the abdominal aorta.
The fall in vascular volume with tumour size has been documented by other workers (Song & Levitt, 1971; Jirtle et al., 1978) (Peterson 1978; Denekamp & Hobson, 1982; Tannock, 1968; Falk, 1978; Vaupel et al., 1981; Rubin & Casarett, 1966) . tumours over the size range measured, the tumours did show individual characteristics in their vessel size distributions at various sizes. In the adenocarcinoma, CaNT, increasing tumour size was accompanied by an increase in larger vessels. Therefore, although the vascular fraction was maintained in larger tumours, it may disguise a decrease in the proportion of nutritionally useful capillaries. If the functional capillary volume is expressed as a fraction of the viable tumour tissue it falls from almost 3% in small CaNT tumours, to about 0.5% in large CaNT tumours (Figure 11 ). This implies that the cells are metabolically less active in large tumours, that the blood flow is more efficient, or that it is inappropriate to consider small vessels as the only nutritionally useful component of the vasculature. In the sarcoma the fraction of viable tissue occupied by the capillary space was between 1 and 2%, with no obvious size dependence.
In conclusion, the fluorescent dye H33342 allows a more detailed study of the vascular patterns in tumours than is possible with isotopic methods. Although it may have a slight effect on vessel tone, it gives estimates of the vascular volume perfused at 1min that are closely similar to those obtained from a 30min perfusion of labelled red blood cells. It is shown to be a stable cell marker which has a rapid clearance from the blood stream, and hence may be suitable for studies in which multiple injections are used to measure changes in vascular space as time is allowed for opening and closing of vessels.
